Unit of Regenerative Medicine

 
Catherine Jackson and Tor Paaske Utheim, group leaders
Catherine Jackson and Tor Paaske Utheim, group leaders

Background:
One of our main goals is to develop storage and transport technology for cultured stem cells of various origins. We anticipate this technology will be increasingly in demand as research in regenerative medicine becomes common practice. Improved treatment for patients with dry eye disease is another research focus, based on analyses of clinical data. Treatment of eye disease at the front and back of the eye is also an important part of our work, especially treatment of limbal stem cell deficiency using alternative cell types, such as cultured epidermal and oral mucosal cells. Isolation and culture of epidermal keratinocytes is thus a recent area of research interest. We specialize in stem cell research mainly in the areas of eye and skin.

 
 

Research projects

 
  • Culture and storage of conjunctival, limbal, epidermal, retinal, and oral mucosal cells
  • Transport technology for cultured cells
  • Isolation and culture of epidermal stem cells
  • Treatment of keratoconus (irregular cornea) and dry eye disease
  • Biomarkers in Sjøgren`s syndrome
  • Imaging technology of eyes, mouth and skin
  • Treatment of deafness by means of regenerative medicine
  • Elucidation of the pathogenesis of pterygium
  • The role of electrostimulation in treating blindness
 
 
 

Contact information:
Group Leader (shared) Catherine Jackson/ Tor Paaske Utheim, Department of Medical Biochemistry
Tel.: +47 90224699/+47 93085870, E-mail: catherinejoanjackson@gmail.com/utheim2@gmail.com